Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2016-09-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jama.2016.11046PMID 27599331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis of Latent Tuberculosis Infection: Too Soon to Pull the Plug on the Tuberculin Skin Test

  2016cited by this paper
• Leveling of Tuberculosis Incidence - United States, 2013-2015.

  2016cited by this paper
• Screening for Latent Tuberculosis Infection in Adults

  2016cited by this paper
• Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2016cited by this paper
• Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012

  2015cited by this paper
• Latent Mycobacterium tuberculosis infection.

  2015cited by this paper
• Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

  2013cited by this paper
• Isoniazid vs. Rifampin for Latent Tuberculosis Infection in Jail Inmates

  2012cited by this paper
• Three months of rifapentine and isoniazid for latent tuberculosis infection.

  2011cited by this paper
• Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection

  2008cited by this paper
• Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.

  2005cited by this paper
• Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC.

  2005cited by this paper
• Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.

  2005cited by this paper
• Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months.

  2004cited by this paper
• Outcomes of contact investigations of infectious tuberculosis patients.

  2000cited by this paper
• Efficacy of various duration of isoniazid preventive therapy for tuberculosis : five years follow-up in the IUAT trial

  1982cited by this paper
• Contacts of cases of active pulmonary tuberculosis.

  1975cited by this paper

• Disparities in testing for latent tuberculosis infection in a large US integrated healthcare system.

  2026cites this paper
• The effectiveness of preventive tuberculosis treatment in children.

  2026cites this paper
• The cascade of care for latent tuberculosis infection in Malaysia: a cohort analysis.

  2026cites this paper
• Policy Impediments to Tuberculosis Elimination: Consequences of an Absent Medicare National Coverage Determination for Tuberculosis Prevention

  2025cites this paper
• Navigating the dual burden of diabetes mellitus and tuberculosis: A comprehensive review of clinical and public health strategies.

  2025cites this paper
• Development and validation of prediction algorithm to identify tuberculosis in two large California health systems

  2025cites this paper
• Low utilization of targeted tuberculosis (TB) infection testing in the United States: A 15-year serial cross-sectional study.

  2025cites this paper
• Latent TB treatment outcomes in patients with chronic liver disease: A retrospective cohort study

  2025cites this paper
• Comparison of Tuberculin Skin Testing and Interferon-γ Release Assays in Predicting Tuberculosis Disease

  2024cites this paper
• Tuberculosis screening for patients on biologic Medications: A Single-Center experience and Society guideline Review, Monroe County, New York, 2018–2021

  2024cites this paper
• Singapore tuberculosis (TB) clinical management guidelines 2024: A modified Delphi adaptation of international guidelines for drug-susceptible TB infection and pulmonary disease.

  2024cites this paper
• Risk of tuberculosis among pulmonary tuberculosis contacts: the importance of time of exposure to index cases.

  2024cites this paper
• Latent tuberculosis infection testing practices in a large U.S. integrated healthcare system.

  2024cites this paper
• Cost-effectiveness of expanded latent TB infection testing and treatment: Lynn City, Massachusetts, USA.

  2024cites this paper
• Determining the Need for Additional Testing With Quantiferon TB Gold in Patients With Positive Tuberculin Skin Tests and a History of BCG Vaccination

  2023cites this paper
• Screening Practices and Risk Factors for Co-Infection with Latent Tuberculosis and Hepatitis B Virus in an Integrated Healthcare System - California, 2008-2019.

  2023cites this paper
• Using Electronic Health Record Data to Measure the Latent Tuberculosis Infection Care Cascade in Safety-Net Primary Care Clinics

  2023cites this paper
• Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States

  2023cites this paper
• On Patient Safety: Latent Tuberculosis-How We Can Help Address This Problem.

  2023cites this paper
• Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection

  2023cites this paper
• Tuberculosis infection following immune checkpoint inhibitor treatment for advanced cancer: a case report and literature review

  2023cites this paper
• Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement.

  2023cites this paper
• Treatment strategies for the latent tuberculosis infections

  2023cites this paper
• Screening for Latent Tuberculosis Infection Among Non-US-Born Adults in the US: A Path Toward Elimination.

  2023cites this paper
• Latent Tuberculosis Infection Treatment Practices in Two Large Integrated Health Systems in California, 2009–2018

  2023cites this paper
• The Global Expansion of LTBI Screening and Treatment Programs: Exploring Gaps in the Supporting Economic Evidence

  2023cites this paper
• Tuberculosis — United States, 2022

  2023cites this paper
• Scaling Up Latent Tuberculosis Infection Testing and Treatment for Non-US Born Patients in a Federally Qualified Community Health Center

  2023cites this paper
• A Literature Review on the Adherence to Screening Guidelines for Latent Tuberculosis Infection Among Persons Living With HIV.

  2023cites this paper
• Randomized Controlled Trial of Clinical Guidelines Versus Interactive Decision-Support for Improving Medical Trainees’ Confidence with Latent Tuberculosis Care

  2023cites this paper
• Diagnosis and Management of Latent Tuberculosis Infection: Updates.

  2023cites this paper
• Diagnosis, Treatment, and Prevention of Tuberculosis Among People Experiencing Homelessness in the United States: Current Recommendations

  2023cites this paper
• Can Primary Care Drive Tuberculosis Elimination? Increasing Latent Tuberculosis Infection Testing and Treatment Initiation at a Community Health Center with a Large Non-U.S.-born Population

  2023cites this paper
• Primary care providers’ and nurses’ knowledge, attitudes, and skills regarding latent TB infection testing and treatment: A qualitative study from Rhode Island

  2022cites this paper
• Deep learning based CT images automatic analysis model for active/non-active pulmonary tuberculosis differential diagnosis

  2022cites this paper
• Association of Area-Based Socioeconomic Measures with Tuberculosis Incidence in California

  2022cites this paper
• Novel Automation of an Enzyme-Linked Immunosorbent Spot Assay Testing Method: Comparable Diagnostic Performance of the T-SPOT.TB Test Using Manual Density Gradient Cell Isolation versus Automated Positive Selection with the T-Cell Select Kit

  2022cites this paper
• Care of Justice-Involved Populations.

  2022cites this paper
• Development and validation of a prediction algorithm to identify birth in countries with high tuberculosis incidence in two large California health systems

  2022cites this paper
• Expanding Latent Tuberculosis Infection Testing and Treatment in Massachusetts Primary Care Clinics via the ECHO Model

  2022cites this paper
• Prevalence trends of latent tuberculosis infection at the global, regional and country levels from 1990 to 2019.

  2022cites this paper
• Reactivation of latent tuberculosis in a COVID-19 patient on corticosteroid treatment

  2022cites this paper
• Evaluation of the latent tuberculosis care cascade among public health clinics in the United States.

  2022cites this paper
• Reviewing a Decade of Outpatient Tropical Medicine in Houston, Texas

  2022cites this paper
• Variability of interferon-γ release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United States.

  2022cites this paper
• A systematic review and meta-analysis of Mycobacterial infections in patients with idiopathic inflammatory myopathies.

  2022cites this paper
• Tuberculin skin tests following Bacille Calmette Guerin vaccination in Africa: a protocol for systematic review and meta-analysis

  2022cites this paper
• Emergency department screening for latent tuberculosis infection.

  2021cites this paper
• The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease

  2021cites this paper
• Cascade of Care in the Management of Latent Tuberculosis Infection in the United States: A Lot to Improve and to Scale Up

  2021cites this paper
• Challenges in LTBI care in the United States identified using a nationwide TB medical consultation database.

  2021cites this paper
• Chequeo preventivo basado en la evidencia

  2021cites this paper
• Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort

  2021cites this paper
• State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity

  2021cites this paper
• Tuberculosis Screening in Silica-Exposed Workers

  2021cites this paper
• Self-Reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection - 2011-2012.

  2021cites this paper
• Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study.

  2021cites this paper
• Incorporation of Social Risk in US Preventive Services Task Force Recommendations and Identification of Key Challenges for Primary Care.

  2021cites this paper
• Diagnosis and Treatment of Latent Tuberculosis Infection.

  2021cites this paper
• Retrospective Performance Analyses of over Two Million U.S. QuantiFERON Blood Sample Results

  2021cites this paper
• TB risk by time since U.S. entry among non-U.S.-born residents of Washington State, USA.

  2021cites this paper
• Integrative Analysis of Human Macrophage Inflammatory Response Related to Mycobacterium tuberculosis Virulence

  2021cites this paper
• A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States

  2021cites this paper
• Epidemiology and Prevention of Tuberculosis and Chronic Hepatitis B Virus Infection in the United States

  2021cites this paper
• Latent Tuberculosis Infection.

  2021cites this paper
• Prevalence of latent tuberculosis in patients with hematological neoplasms in a cancer referral hospital in Mexico City

  2021cites this paper
• Experiences with Diagnosis and Treatment of Chagas Disease at a United States Teaching Hospital—Clinical Features of Patients with Positive Screening Serologic Testing

  2021cites this paper
• Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States

  2020cites this paper
• Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California.

  2020cites this paper
• Identifying gaps in the quality of latent tuberculosis infection care

  2020cites this paper
• Tuberculosis Infection Among People With Diabetes: United States Population Differences by Race/Ethnicity.

  2020cites this paper
• US Tuberculosis Rates among Persons Born Outside the United States Compared with Rates in Their Countries of Birth, 2012–2016

  2020cites this paper
• Health screenings administered during the domestic medical examination of refugees and other eligible immigrants in nine US states, 2014–2016: A cross-sectional analysis

  2020cites this paper
• Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literature.

  2020cites this paper
• Should immune checkpoint inhibitors be contraindicated in lung cancer patients with latent tuberculosis?

  2020cites this paper
• Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texas.

  2020cites this paper
• Diabetes mellitus among adults with tuberculosis in the USA, 2010–2017

  2020cites this paper
• Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States

  2020cites this paper
• Programmatic Effectiveness of Latent Tuberculosis Care Cascade in a Community Health Center

  2020cites this paper
• Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association

  2020cites this paper
• Modeling the Impact of Recommendations for Primary Care–Based Screening for Latent Tuberculosis Infection in California

  2020cites this paper
• Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination

  2020cites this paper
• Estimated Latent Tuberculosis Infection Prevalence and Tuberculosis Reactivation Rates Among Non-U.S.-Born Residents in the United States, from the 2011–2012 National Health and Nutrition Examination Survey

  2020cites this paper
• Latent Tuberculosis Screening Using Electronic Health Record Data

  2020cites this paper
• Association of Mortality and Years of Potential Life Lost With Active Tuberculosis in the United States

  2020cites this paper
• Tuberculosis Infection in Children.

  2020cites this paper
• Prevalence of Latent Tuberculosis Infection among Non-U.S.-Born Persons by Country of Birth - United States, 2012-2017.

  2020cites this paper
• Occupational Respiratory Infections.

  2020cites this paper
• Acceptability and Feasibility of a Nurse-Led, Community Health Worker Partnered Latent Tuberculosis Medication Adherence Model for Homeless Adults

  2020cites this paper
• Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data

  2020cites this paper
• COVID-19 epidemic in the US—A gateway to screen for tuberculosis, HIV, viral hepatitides, Chagas disease, and other neglected tropical diseases among Hispanics

  2020cites this paper
• Cancer risk in tuberculosis patients in a high endemic area

  2020cites this paper
• Impact of An Internal Medicine-Pediatrics Residency Quality Improvement Project to Increase Latent Tuberculosis Screening.

  2020cites this paper
• Tuberculosis

  2020cites this paper
• Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness

  2019cites this paper
• Estimated impact of World Health Organization latent tuberculosis screening guidelines in a low TB incidence region: retrospective cohort study.

  2019cites this paper
• One Step toward a Low Tuberculosis-Burden Country: Screening for Tuberculosis Infection among the Immigrants and Refugees

  2019cites this paper
• Epidemiological impact of targeted interventions for people with diabetes mellitus on tuberculosis transmission in India: Modelling based predictions.

  2019cites this paper
• Robustness of NHANES Estimates of the US Prevalence of a Positive Tuberculin Skin Test

  2019cites this paper
• Treatment of Latent Tuberculosis Infection-An Update.

  2019cites this paper